Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-Azacytidine

Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

(2012) Drorit Merkel et al.   AMERICAN JOURNAL OF HEMATOLOGY

Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature

(2012) D. Borchiellini et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

(2011) T. Braun et al.   BLOOD

Impact of the hypomethylating agent 5-azacytidine on dendritic cells function

(2011) Jihane Frikeche et al.   EXPERIMENTAL HEMATOLOGY

Hematopoietic Growth Factors in Myelodysplastic Syndromes

(2011) David P. Steensma   SEMINARS IN ONCOLOGY

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

(2010) O. Goodyear et al.   BLOOD

Activity of azacitidine in chronic myelomonocytic leukemia

(2010) Rubens Costa et al.   CANCER

Decreased incidence of febrile episodes with antibiotic prophylaxis in the treatment of decitabine for myelodysplastic syndrome

(2010) Je-Hwan Lee et al.   LEUKEMIA RESEARCH

Therapy with azanucleosides for myelodysplastic syndromes

(2010) Alfonso Quintás-Cardama et al.   Nature Reviews Clinical Oncology

How I treat patients with myelodysplastic syndromes

(2009) R. M. Stone   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?

(2009) S. Dalle et al.   BRITISH JOURNAL OF DERMATOLOGY

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

(2009) Elias Jabbour et al.   CANCER

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

(2009) Pierre Fenaux et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

(2009) Pierre Fenaux et al.   LANCET ONCOLOGY

A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm

(2009) Wing Y. Au et al.   LEUKEMIA & LYMPHOMA